The EU drug regulator could approve Covid-19 vaccines that have been adapted to target the new variant within three to four months if needed, the agency's chief said on Tuesday as she said existing shots would continue to provide protection.
Speaking to the European Parliament, European Medicines Agency (EMA) executive director Emer Cooke said it was not known if drugmakers would need to tweak their vaccines to protect against Omicron, but the agency was preparing for that possibility.
"Even if the new variant becomes more widespread, the vaccines we have will continue to provide protection," she said.
Her comments came as drugmaker Moderna's CEO set off fresh alarm bells in financial markets on Tuesday after he warned that vaccines were unlikely to be as effective against the variant first detected in southern Africa as they have been against the Delta version.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Blinken to Putin: Choose peaceful path on Ukraine
Rooney ascent raises prospect of Everton return
Coach Arteta vows to defend Arsenal with ‘teeth and nails’
Yorkshire appoint Gibson as coach after racism scandal
Putin, Raisi hail ties at decisive moment for Iran nuclear deal
UK PM Johnson faces growing pressure to resign
UK PM Johnson faces plot to trigger leadership challenge
Ex-veteran Kazakhstan leader denies conflict with successor
British PM denies lying about ‘lockdown party’